Evolent Health Inc. is taking steps to expand its arsenal of services for health care providers, starting with an acquisition that will move it into the lucrative area of musculoskeletal care.
The Arlington company, which helps health systems and insurance companies manage their costs and improve care, charges into the second half of 2022 on the cusp of closing its purchase of Alpharetta, Georgia’s IPG. That deal, worth up to $462 million, would give the local firm a foothold in a business line that Evolent co-founder and CEO Seth Blackley said is crucial to its long-term success.
The 11-year-old Evolent (NYSE: EVH) helps providers and payors shift their business models from getting paid per procedure to getting paid based on good health outcomes. It operates in two areas: primary and specialty care. The latter includes oncology and cardiology, as well as the end-of-life period for patients.
Evolent “scanned the landscape” for a company doing similar work in the musculoskeletal…
Read the full story from the Washington Business Journal.
